Supplement analysis backed by scientific evidence · PT

← All supplements
Moderate evidenceHeart & metabolic

CoQ10 (Ubiquinone)

CoQ10 has reasonable evidence for symptom and outcome improvement in chronic heart failure as an add-on to standard therapy, and a modest blood pressure effect. Its most popular use — fixing statin muscle pain — is not well supported by meta-analysis.

What the science says

  • Adjunct therapy in chronic heart failure Moderate evidence

    The Q-SYMBIO RCT (n=420, 300 mg/day for 2 years) reported fewer major adverse cardiovascular events with CoQ10 (15% vs 26%) and lower all-cause mortality (10% vs 18%) on top of guideline therapy. A 2024 meta-analysis of RCTs found improved ejection fraction and exercise capacity, but effect sizes vary and most trials are small, single-centre and pre-date modern HF therapy (SGLT2 inhibitors, ARNI).

  • Relief of statin-associated muscle symptoms Limited evidence

    A 2020 systematic review and meta-analysis of 12 RCTs found no significant reduction in statin-associated myalgia with CoQ10 versus placebo — neither in muscle pain scores nor in creatine kinase. Statins do lower circulating CoQ10 concentrations, but restoring them has not translated into symptom relief in controlled trials.

  • Blood pressure reduction Limited evidence

    Pooled trials suggest a small systolic reduction of roughly 3-5 mmHg at 100-200 mg/day, but the trials are small, heterogeneous and often unblinded for outcome assessment. Treat it as a possible minor add-on, not an antihypertensive.

Dosage & safety

Studied dose100-300 mg/day, usually split into 2-3 doses with a fat-containing meal (absorption is poor on an empty stomach). Heart failure trials used 300 mg/day (100 mg three times daily); blood pressure and general-wellness trials used 100-200 mg/day. Ubiquinol (the reduced form) is marketed as better absorbed, but head-to-head clinical superiority is not established, and it costs considerably more. Effects on heart failure endpoints took 3 months to 2 years to appear.
SafetyGenerally well tolerated. The most common complaints are mild nausea, appetite loss, diarrhoea and, occasionally, insomnia when taken late in the day. CoQ10 is structurally related to vitamin K and can modestly reduce the anticoagulant effect of warfarin — anyone on warfarin should have INR monitored when starting or stopping it. Doses above 300 mg/day may raise liver enzymes in some people. Data in pregnancy and breastfeeding are insufficient. It does not replace prescribed heart failure or blood pressure medication, and stopping those in favour of CoQ10 is dangerous.

Scientific references

Where to buy

California Gold Nutrition, CoQ10, Ubiquinone USP with BioPerine® Black Pepper Extract, Enhanced Bioavailability, 150 Veggie Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic